CX1739 is a weak modulator of the AMPA-glutamate receptor (AMPAR). In mouse models, CX1739 enhances long-term potentiation in a dose-dependent manner. It also counteracts amphetamine-induced locomotor activity and rapidly reverses opioid-induced respiratory depression. CX1739 is applicable for research into dementia, neuropsychiatric disorders, and severe complications arising from opioid-induced suppression of endogenous inspiratory respiratory rhythms.
Molekulargewicht:
261.28
CAS Nummer:
[1086377-48-1]
Formel:
C13H15N3O3
Target-Kategorie:
iGluR
T211052
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
